Idiopathic Thrombocytopenic Purpura
📧 Sign up to get email alerts when something new happens for Idiopathic Thrombocytopenic Purpura.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-04Clinical Trial Update: An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias [Phase 1, Phase 2]
Open-label Phase 1/2 study evaluating povetacicept in autoimmune cytopenias. The study includes immune thrombocytopenia and idiopathic throm…
-
CLINICAL_TRIALS research · 2025-01-03Clinical Trial Update: Special Drug Use-results Survey for Long-term Use (Fostamatinib)
A long-term use results survey for fostamatinib in chronic idiopathic thrombocytopenic purpura is being conducted, with the study currently …
-
CLINICAL_TRIALS research · 2017-12-06Clinical Trial Update: Sirolimus for Autoimmune Disease of Blood Cells [Phase 1, Phase 2]
A phase 1/2 trial evaluating sirolimus for autoimmune blood cell disorders, including autoimmune pancytopenia and ALPS; the study is complet…
-
CLINICAL_TRIALS research · 2016-07-25Clinical Trial Update: Promacta Pregnancy Registry
This update notes the completion of GlaxoSmithKline's Promacta (eltrombopag) pregnancy registry, which monitors pregnancy outcomes in women …